Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.1
33.48%
40%
—
2.06%
80%
—
5 Years
Score5.1
Net Growth33.48%
Net Trend40%
Net Income Consistency—
Rev Growth2.06%
Rev Trend80%
Revenue Consistency—
Mednax Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 1.73B to $ 1.91B and net income went from -$ 796M to $ 165M. Revenue increased in 4 of those 5 years; net income in 2.
Across Mednax Inc's full reported history, from 1995 to 2025, revenue grew from $ 43M to $ 1.91B and net income grew from $ 6M to $ 165M. Revenue increased in 90% of the years measured; net income in 68%.
Mednax Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 26.50 | — |
1 Year2025-08-12 | $ 14.72 | 80.03% |
5 Years2021-08-12 | $ 33.80 | -21.60% |
10 Years2016-08-12 | $ 65.75 | -59.70% |
20 Years2006-08-11 | $ 21.54 | 23.03% |
30 Years1996-08-12 | $ 12.44 | 113.07% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 |
|---|---|---|---|---|---|---|
| Price | $ 26.50 | $ 14.72 | $ 33.80 | $ 65.75 | $ 21.54 | $ 12.44 |
| Return | — | 80.03% | -21.60% | -59.70% | 23.03% | 113.07% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.95B | $ 174M | $ 404M |
| 2025 | $ 1.91B | $ 165M | $ 499M |
| 2024 | $ 2.01B | -$ 99M | $ 348M |
| 2023 | $ 1.99B | -$ 60M | $ 177M |
| 2022 | $ 1.97B | $ 66M | $ 103M |
| 2021 | $ 1.91B | $ 130M | $ 487M |
| 2020 | $ 1.73B | -$ 796M | $ 1.22B |
| 2019 | $ 1.77B | -$ 1.49B | $ 182M |
| 2018 | $ 3.64B | $ 268M | $ 58M |
| 2017 | $ 3.45B | $ 320M | $ 70M |
| 2016 | $ 3.18B | $ 324M | $ 66M |
| 2015 | $ 2.77B | $ 336M | $ 60M |
| 2014 | $ 2.43B | $ 317M | $ 53M |
| 2013 | $ 2.15B | $ 280M | $ 37M |
| 2012 | $ 1.81B | $ 240M | $ 27M |
| 2011 | $ 1.58B | $ 217M | $ 22M |
| 2010 | $ 1.40B | $ 202M | $ 43M |
| 2009 | $ 1.28B | $ 175M | $ 31M |
| 2008 | $ 1.06B | $ 169M | $ 35M |
| 2007 | $ 917M | $ 142M | $ 120M |
| 2006 | $ 818M | $ 124M | |
| 2005 | $ 693M | $ 89M | $ 22M |
| 2004 | $ 619M | $ 98M | $ 16M |
| 2003 | $ 551M | $ 84M | $ 27M |
| 2002 | $ 465M | $ 68M | $ 73M |
| 2001 | $ 354M | $ 30M | $ 27M |
| 2000 | $ 243M | $ 10M | $ 3M |
| 1999 | $ 227M | $ 25M | $ 800K |
| 1998 | $ 185M | $ 29M | $ 700K |
| 1997 | $ 128M | $ 20M | $ 18M |
| 1996 | $ 80M | $ 13M | $ 18M |
| IPO1995 | $ 43M | $ 6M | $ 18M |
Explore beyond MD
You're looking at Mednax Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
